Sex: F
Vaccine: COVID19
Symptoms: Pruritus, SARS-CoV-2 test, Urticaria, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Injection site swelling with itching; Injection site swelling with itching; itching with hives of face, neck, scalp; hives; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching with hives of face, neck, scalp), URTICARIA (hives), VACCINATION SITE PRURITUS (Injection site swelling with itching) and VACCINATION SITE SWELLING (Injection site swelling with itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     The patient's past medical history included Autoimmune disorder since an unknown date and COVID-19 on 20-Dec-2020. Concurrent medical conditions included Flu vaccination. Concomitant products included PAROXETINE HYDROCHLORIDE (PAXIL [PAROXETINE HYDROCHLORIDE]) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced PRURITUS (itching with hives of face, neck, scalp) and URTICARIA (hives). On 19-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site swelling with itching) and VACCINATION SITE SWELLING (Injection site swelling with itching). On 10-Mar-2021, PRURITUS (itching with hives of face, neck, scalp) and URTICARIA (hives) had resolved. On 20-Mar-2021, VACCINATION SITE PRURITUS (Injection site swelling with itching) and VACCINATION SITE SWELLING (Injection site swelling with itching) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Dec-2020, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-Mar-2021 and was forwarded to Moderna on 25-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching with hives of face, neck, scalp), URTICARIA (hives), VACCINATION SITE PRURITUS (Injection site swelling with itching) and VACCINATION SITE SWELLING (Injection site swelling with itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     The patient's past medical history included Autoimmune disorder since an unknown date and COVID-19 on 20-Dec-2020. Concurrent medical conditions included Flu vaccination. Concomitant products included PAROXETINE HYDROCHLORIDE (PAXIL [PAROXETINE HYDROCHLORIDE]) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced PRURITUS (itching with hives of face, neck, scalp) and URTICARIA (hives). On 19-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site swelling with itching) and VACCINATION SITE SWELLING (Injection site swelling with itching). On 10-Mar-2021, PRURITUS (itching with hives of face, neck, scalp) and URTICARIA (hives) had resolved. On 20-Mar-2021, VACCINATION SITE PRURITUS (Injection site swelling with itching) and VACCINATION SITE SWELLING (Injection site swelling with itching) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Dec-2020, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        No treatment information was provided.